Clinical Trial

Implementation of a Clinical Decision Support System in Primary Care for the Screening and Assessment of Frailty in Patients Aged 65 and Over

Study acronym: FRAGICLIC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to evaluate the real-life use of a digital tool (Fragiclic) by general practitioners (GPs) and nurses to screen and assess frailty in adults aged 65 and over. Frailty is a syndrome that increases the risk of loss of autonomy, falls, hospitalizations, or death. The tool includes simple screening questionnaires (such as SEGAm) and a comprehensive assessment (CGA - Comprehensive Geriatric Assessment) to better manage patients' health. The main question it aims to answer is: * What proportion of patients aged 65 and over will benefit from frailty screening or assessment using Fragiclic over 12 months? A secondary question is \- Does the use of Fragiclic reduce the risk of unplanned hospitalizations or death in these patients? For the secondary question, researchers will compare patients who received screening or assessment (with or without a Personalized Care Plan (PCP)) to those who did not, to determine if Fragiclic improves their health outcomes. Participants will not have additional tasks: Their GP or nurse will use Fragiclic during routine consultations. Some patients may be asked to provide information about their health or quality of life (via their healthcare provider). All data will be collected anonymously and securely
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-04-30; most recent amendment 2026-05-11.
Trial Details
NCT Number NCT07570628
Lead Sponsor CNGE Conseil
Conditions Frailty at Older Adults, Primary Care, Geriatric Assessment, Implementation Research, Interprofessional Collaboration
Enrollment 726 participants
Start Date 2027-01-02
Primary Completion 2028-04-01 (estimated)
Study Completion 2029-01-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-13